Merck's earnings call highlighted strong financial performance, exceeding expectations despite currency headwinds, and provided positive guidance for 2016. Management's optimistic tone, emphasis on innovative products like KEYTRUDA and ZEPATIER, and anticipated growth from new product launches suggest short-term confidence. These factors are likely to positively influence the stock price in the next 1â€“2 weeks.

[1]